Indeed, our analysis of NLRP3 (and CASP1 and IL‐1β) expression in 90 pediatric ALL PDX samples (PPTC data set)19 using the PedcBioPortal database confirmed higher NLRP3 mRNA expression in ALL compared to other cancer types. This evidence concerns the gene IL1B and acute lymphoblastic leukemia.